Why Hasn’t the U.S. Found More Omicron Cases?
Genomic surveillance has improved enormously in recent months, but the system has built-in delays, and blind spots remain.
View original article
Contributor: Emily Anthes
Genomic surveillance has improved enormously in recent months, but the system has built-in delays, and blind spots remain.
View original article
Contributor: Emily Anthes